IPP Bureau
Prasad Raghava Menon appointed Additional Director of Neuland Laboratories
By IPP Bureau - November 01, 2022
Menon has over 41 years of diverse experience in some of the premier multinational and Indian companies in the chemical and power industry
Ashland injectable pharmaceutical excipient accepted into FDA Novel Excipient Review Pilot Program
By IPP Bureau - November 01, 2022
The voluntary program is the first time the FDA will allow excipient manufacturers to obtain review of certain novel excipients prior to their use in drug formulations.
Aptar Pharma completes Phase I global injectables expansion program
By IPP Bureau - November 01, 2022
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
Alembic Pharma gets USFDA approval for Glycopyrrolate Injection USP
By IPP Bureau - November 01, 2022
This is the first injectable product approval from our General Sterile Facility (F-3) which was inspected in August, 2022.
Sustaining growth momentum is key for Navin Fluorine: ICICI Securities
By IPP Bureau - October 31, 2022
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
USFDA issues Form-483 for Lupin's Nagpur Unit-2
By IPP Bureau - October 31, 2022
The company is committed to addressing the observations at the earliest, and gaining approval for injectable manufacturing for the US
USFDA determines inspection classification of Jubilant Pharmova's Roorkee facility
By IPP Bureau - October 31, 2022
The company currently supplies one product to the US market that contributes low- single digit revenue to Jubilant Pharmova revenue
Zydus receives final approval from USFDA for Acetaminophen injection
By IPP Bureau - October 30, 2022
Acetaminophen injection had annual sales of US $72 million in the United States according to IQVIA data
Kopran acquire assets of Abhinandan Rasayan
By IPP Bureau - October 30, 2022
Once the unit is made fully functional, it will help the company in increasing its API and intermediate production capacity
USFDA issues Form 483 for Parawada unit of Laurus Labs
By IPP Bureau - October 30, 2022
The observation is procedural in nature and the company will address the observation within stipulated timelines.
Madhur Gundecha appointed CFO of Astec Lifesciences
By IPP Bureau - October 30, 2022
He has over 23 years' experience working in leading companies such as Omniactive Health Technologies, Johnson Matthey Chemicals, BASF, Godrej Agrovet Limited & Bharat Petroleum Corporation Limited.
21.4 lakh TB cases notified in India in 2021
By IPP Bureau - October 30, 2022
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
Recent launch of 5G will bring a new revolution in digital healthcare: Dr. Singh
By IPP Bureau - October 30, 2022
India will become a digital health leader, as we have the world’s best technical manpower required and our data is the cheapest in the world, approaching 100 percent coverage
Granules India plans H2 FY 2022-23 R&D spend in Rs. 80-90 Cr
By IPP Bureau - October 30, 2022
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
Mandaviya addresses Second G20 Health Ministers Meet
By IPP Bureau - October 28, 2022
He also encouraged all G20 members to contribute their public keys to the proposed Global Federated Public Trust Directory for ensuring seamless worldwide mobility of people and goods
